Joseph Kassab, Serge C Harb, Milind Y Desai, A Marc Gillinov, Habib Layoun, Joseph El Dahdah, Michel Chedid El Helou, Shady Nakhla, Haytham Elgharably, Samir R Kapadia, Paul C Cremer, Amgad Mentias
BACKGROUND: Data regarding permanent pacemaker (PPM) implantation following tricuspid valve surgery (TVS) are limited. We sought to evaluate its incidence, risk factors, and outcomes. METHODS AND RESULTS: Medicare beneficiaries who underwent TVS from 2013 to 2020 were identified. Patients who underwent TVS for endocarditis were excluded. The primary exposure of interest was new PPM after TVS. Outcomes included all-cause mortality and readmission with endocarditis or heart failure on follow-up...
January 31, 2024: Journal of the American Heart Association